Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Takeda Pharmaceutical Co Ltd (PK) (TKPHF)
Takeda Pharmaceutical Co Ltd (PK) (TKPHF) Actualités

TKPHF

Takeda Pharmaceutical (PK) (TKPHF)

Takeda Pharmaceutical Co Ltd (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:TKPHF

1

Date	Heure	Source	Titre	Symbole	Société
13/02/2025	12h40	Edgar (US Regulatory)	Form 13F-HR - Quarterly report filed by institutional managers, Holdings	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
13/02/2025	12h06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
23/08/2024	02h36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
05/02/2024	12h24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
28/06/2023	12h36	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
23/06/2023	12h15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
15/05/2023	12h37	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
07/02/2023	20h12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
29/05/2020	12h27	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
03/03/2020	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
26/02/2020	12h10	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
14/11/2019	12h12	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
12/11/2019	15h51	Edgar (US Regulatory)	Amended Securities Registration (foreign Private Issuer) (f-4/a)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
09/08/2019	12h29	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-4)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
27/06/2019	12h43	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
14/02/2019	20h16	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
09/06/2015	17h06	The Motley Fool	Obesity Drugs: Stocks to Watch	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
16/05/2015	17h04	The Motley Fool	Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
23/03/2015	20h25	The Motley Fool	Why ImmunoGen Inc. is Soaring Higher Today	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
23/03/2015	17h14	The Motley Fool	Why ImmunoGen, Inc. is Soaring Higher Today	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
13/12/2012	06h00	OTC Markets	Piggyback Qualified	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
13/11/2012	14h18	OTC Markets	Venue Change	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
13/11/2012	06h00	OTC Markets	Tier Change	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)
20/09/2012	11h00	Zacks	FDA Panel to Review Celgene Drug - Analyst Blog	USOTC:TKPHF	Takeda Pharmaceutical Co Ltd (PK)

Showing the most relevant articles for your search:USOTC:TKPHF

1

Lvmh Moet Hennessy Louis...

Societe Generale

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales